Polymer Capital Management (Us) LLC Iovance Biotherapeutics, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 55,582 shares of IOVA stock, worth $97,824. This represents 0.05% of its overall portfolio holdings.
Number of Shares
55,582Holding current value
$97,824% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
337Shares Held
243MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$48.9 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$43 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$37.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$22.4 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$19.4 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $278M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...